SPARC and breast cancer: Cathepsin K from breast cancer cells activates osteoclasts, which promotes osteolytic bone metastasis [85,86], and cathepsin K from the bone marrow stromal cells promotes breast cancer bone metastasis by splicing and activating SPARC in breast cancer cells [87].